AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $304,000 | +130.3% | 862,168 | +367.4% | 0.00% | – |
| Q1 2022 | $132,000 | -28.6% | 184,465 | +125.6% | 0.00% | – |
| Q4 2021 | $185,000 | -11.9% | 81,774 | +12.4% | 0.00% | – |
| Q3 2021 | $210,000 | +296.2% | 72,770 | +419.1% | 0.00% | – |
| Q2 2021 | $53,000 | -60.2% | 14,019 | -64.3% | 0.00% | – |
| Q1 2021 | $133,000 | -76.2% | 39,248 | -80.4% | 0.00% | -100.0% |
| Q4 2020 | $560,000 | -39.3% | 200,093 | -45.5% | 0.00% | -50.0% |
| Q3 2020 | $922,000 | -70.4% | 367,286 | +60.3% | 0.00% | -60.0% |
| Q2 2020 | $3,111,000 | +89.0% | 229,059 | +5.5% | 0.01% | +66.7% |
| Q1 2020 | $1,646,000 | -12.4% | 217,123 | -27.0% | 0.00% | +50.0% |
| Q4 2019 | $1,880,000 | +434.1% | 297,479 | +231.4% | 0.00% | – |
| Q3 2019 | $352,000 | +551.9% | 89,771 | +701.8% | 0.00% | – |
| Q2 2019 | $54,000 | -75.0% | 11,196 | -50.5% | 0.00% | – |
| Q1 2018 | $216,000 | -63.5% | 22,622 | -43.2% | 0.00% | -100.0% |
| Q4 2017 | $592,000 | -41.7% | 39,831 | -22.8% | 0.00% | 0.0% |
| Q3 2017 | $1,015,000 | – | 51,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |